Medicine and Dentistry

1. Age 12%
2. Anticoagulation 5%
3. Antithrombotic 31%
4. Apixaban 5%
5. Apoplexy 19%
6. Atrial Fibrillation Ablation 31%
7. Brain Embolism 10%
8. Cardiac Dysrhythmia 8%
9. Cardiovascular System 6%
10. Cardioversion 10%
11. Combination Therapy 44%
12. Complication 63%
13. Consensus 63%
14. Dabigatran 5%
15. Diabetes 9%
16. Dilated Cardiomyopathy 9%
17. Disease 9%
18. Edoxaban 5%
19. Ejection Fraction 13%
20. Enalapril Maleate 5%
21. End Stage Renal Disease 7%
22. Ertugliflozin 31%
23. Female 12%
24. Follow up 10%
25. Heart Failure 9%
26. Heart Failure with Reduced Ejection Fraction 9%
27. Heart Ventricle Arrhythmia 40%
28. Hemoglobin 11%
29. Implantable Automatic Defibrillator 45%
30. Incidence 10%
31. Inpatient 95%
32. Ischemic Cardiomyopathy 17%
33. Laboratory 35%
34. Lead 12%
35. Lesion 31%
36. Magnetic Resonance Imaging 5%
37. Multivariate Analysis 9%
38. Patient 100%
39. Placebo 9%
40. Position 6%
41. Primary Prevention 9%
42. Pulmonary Vein Isolation 10%
43. Rivaroxaban 5%
44. Shock (Circulatory) 27%
45. Sodium Glucose Cotransporter 2 9%
46. Subcutaneous Implantable Cardioverter Defibrillator 38%
47. Therapeutic Procedure 8%
48. Thromboembolism 31%
49. Ventricular Tachycardia 36%
50. Vitamin K Antagonist 31%